The Unique Role That WHO Could Play in Implementing Phage Therapy to Combat the Global Antibiotic Resistance Crisis

被引：8

作者：

Fauconnier, Alan ^{[1
]}

Nagel, Tobi E. ^{[2
]}

Fauconnier, Charlotte ^{[1
]}

Verbeken, Gilbert ^{[3
]}

De Vos, Daniel ^{[3
]}

Merabishvili, Maia ^{[3
]}

Pirnay, Jean-Paul ^{[3
]}

机构：

[1] Culture Vivo ASBL, Nivelles, Belgium

[2] Phages Global Hlth, Oakland, CA USA

[3] Queen Astrid Mil Hosp, Lab Mol & Cellular Technol, Brussels, Belgium

来源：

FRONTIERS IN MICROBIOLOGY | 2020年 / 11卷

关键词：

phage therapy; World Health Organization; low and middle-income countries; regulatory framework; local production; GMP; database; deep learning;

D O I：

10.3389/fmicb.2020.01982

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

[No abstract available]

引用

页数：6

共 20 条

[1]

Abedon Stephen T, 2011, Bacteriophage, V1, P66

[2]

[Anonymous], 2015, Global Antimicrobial Resistance Surveillance System: manual for early implementation

[3]

[Anonymous], 2015, Global Action Plan on Antimicrobial Resistance

[4]

[Anonymous], 2019, INTERAGENCY STATEMEN

[5]

Chanishvili N., 2009, A literature review of the practical application of bacteriophage research, V1st

[6]

De Vos D., 2015, PHAGE THERAPY COULD

[7] Twenty-five years of the WHO vaccines prequalification programme (1987-2012): Lessons learned and future perspectives [J].

Dellepiane, Nora ;

Wood, David .

VACCINE, 2015, 33 (01) :52-61

[8]

Henein Alexandra, 2013, Bacteriophage, V3, pe24872

[9] Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria [J].

Kortright, Kaitlyn E. ;

Chan, Benjamin K. ;

Koff, Jonathan L. ;

Turner, Paul E. .

CELL HOST & MICROBE, 2019, 25 (02) :219-232

[10]

Minssen T., 2014, REVIVAL PHAGE THER 2

← 1 2 →